🇪🇺 Cymbalta in European Union

Cymbalta (duloxetine) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/003981
  • Local brand name: Duloxetine Viatris (previously Duloxetine Mylan)
  • Status: approved

Cymbalta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Cymbalta approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Cymbalta in European Union?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.